118 related articles for article (PubMed ID: 22577750)
1. Cushing's disease and dural invasion.
Hueng DY; Ma HI; Chen CM
J Neurosurg; 2012 Jul; 117(1):189-90; author reply 190-1. PubMed ID: 22577750
[No Abstract] [Full Text] [Related]
2. Invasion of the corticotrophs.
Mayberg MR
J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
[No Abstract] [Full Text] [Related]
3. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
[TBL] [Abstract][Full Text] [Related]
5. Screening for ACTH-dependent hypercortisolism in patients with pituitary incidentaloma.
Torpy DJ
Eur J Endocrinol; 2015 Apr; 172(4):C1-4. PubMed ID: 25609777
[No Abstract] [Full Text] [Related]
6. Current status on histological classification in Cushing's disease.
Syro LV; Rotondo F; Cusimano MD; Di Ieva A; Horvath E; Restrepo LM; Wong M; Killinger DW; Smyth H; Kovacs K
Pituitary; 2015 Apr; 18(2):217-24. PubMed ID: 25501318
[TBL] [Abstract][Full Text] [Related]
7. Rare case of Cushing's disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk.
Mendola M; Dolci A; Piscopello L; Tomei G; Bauer D; Corbetta S; Ambrosi B
Hormones (Athens); 2014; 13(4):574-8. PubMed ID: 25402386
[TBL] [Abstract][Full Text] [Related]
8. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
Saeger W
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
[No Abstract] [Full Text] [Related]
9. Reversible "brain atrophy" in patients with Cushing's disease.
Gnjidić Z; Sajko T; Kudelić N; Malenica M; Vizner B; Vrkljan M; Hat J; Rumboldt Z
Coll Antropol; 2008 Dec; 32(4):1165-70. PubMed ID: 19149224
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome.
Jornayvaz FR; Assie G; Bienvenu-Perrard M; Coste J; Guignat L; Bertherat J; Silvera S; Bertagna X; Legmann P
J Clin Endocrinol Metab; 2011 Apr; 96(4):E658-62. PubMed ID: 21289243
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities in Cushing's disease.
Sharma ST; Nieman LK; Feelders RA
Pituitary; 2015 Apr; 18(2):188-94. PubMed ID: 25724314
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors.
Tamada D; Kitamura T; Otsuki M; Oshino S; Saitoh Y; Shimomura I
Endocr J; 2016; 63(1):47-52. PubMed ID: 26536898
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and mortality of Cushing's syndrome.
Hakami OA; Ahmed S; Karavitaki N
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101521. PubMed ID: 33766428
[TBL] [Abstract][Full Text] [Related]
14. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
15. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
[TBL] [Abstract][Full Text] [Related]
16. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
[TBL] [Abstract][Full Text] [Related]
18. Approach to the postoperative patient with Cushing's disease.
Rutkowski MJ; Breshears JD; Kunwar S; Aghi MK; Blevins LS
Pituitary; 2015 Apr; 18(2):232-7. PubMed ID: 25702104
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Cushing's disease: an update.
Perez-Rivas LG; Reincke M
J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
[TBL] [Abstract][Full Text] [Related]
20. Silent corticotroph adenoma.
Rajesh A
Neurosurgery; 2013 Jul; 73(1):E191-2. PubMed ID: 23615102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
